Steven Riesinger

Dr. Riesinger has over 15 years’ experience in organic chemistry, 9 of those in the biotech arena where he has been involved in the start up of three companies. Dr, Riesinger received his Ph.D. at Emory University in organic chemistry followed by postdoctoral fellowships at Uppsala University with Dr. Jan-E Bäckvall and at Montana State University in the laboratory of Dr. Tom Livinghouse.

During Dr. Riesinger’s tenure at Shionogi BioResearch he spearheaded the initial set up of the medicinal and combinatorial chemistry laboratories and was responsible for managing its lead anti-cancer program.

As a founding scientist at Enanta Pharmaceuticals, Dr. Riesinger played a lead role in setting up the company’s research laboratories, establishing the medicinal chemistry group, and directing its anti-viral programs, which ultimately produced protease inhibitors active in the single-digit nanomolar range.